NorthX Biologics
Janet Hoogstraate is the Chief Executive Officer at NorthX Biologics, where she also serves as the Site Manager and Board Member. She is also a Board Member at AlzeCure Pharma and Mireca Medicines GmbH. Additionally, she is an Advisory Board Member at the Dutch Chamber of Commerce in Sweden. Janet has a background in chemistry and bio-pharmaceutical sciences, with a Master of Business Administration from Hult International Business School. Her experience includes leadership roles at Valneva, AstraZeneca R&D, and Acturum Life Science AB. Janet has also served in various advisory and board positions in the pharmaceutical and life science industry.
NorthX Biologics
1 followers
NorthX Biologics AB is a 7,000 square meter GMP facility in Matfors, Sweden. At NorthX Biologics we take pride in providing services from early development to commercialisation of biopharmaceuticals. Our main but not exclusive focus is to provide support to cell and gene therapy projects and products. We specialise in: Process development Large Scale DNA pDNA HQ DNA Microbial production Formulation QC, QA, QP